OTCMKTS:PSID PositiveID (PSID) Stock Price, News & Analysis $0.0001 0.00 (-50.00%) As of 03/26/2020 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About PositiveID Stock (OTCMKTS:PSID) Get PositiveID alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000250-Day Range N/A52-Week Range$0.0001▼$0.0002Volume32.70 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview PositiveID Corp (OTCMKTS:PSID) is a life sciences company specializing in the development and commercialization of molecular diagnostic assays, detection platforms and health information technology solutions. The company’s molecular diagnostics business is focused on creating point-of-care tests for the rapid and accurate identification of infectious pathogens, environmental contaminants and chemical agents. These offerings leverage immunoassay and biosensor technologies to support applications in healthcare, public health and industrial testing environments. In its health information technology segment, PositiveID offers software and mobile solutions aimed at real-time electronic disease surveillance, laboratory reporting and outbreak management. The company’s platforms are designed to facilitate secure data exchange and analytics for public health agencies and healthcare providers, supporting efforts to accelerate case reporting and improve situational awareness during epidemics. Integrations encompass electronic laboratory reporting interfaces and mobile delivery to state and local health jurisdictions. Founded in 1999 and headquartered in Austin, Texas, PositiveID serves public health agencies, hospitals and diagnostic laboratories across North America. The company holds a portfolio of patents and proprietary technologies, and its management team brings expertise in molecular diagnostics, digital health and regulatory affairs. PositiveID continues to pursue strategic collaborations and product development initiatives to address emerging public health challenges and expand its diagnostic and digital health offerings.AI Generated. May Contain Errors. Read More Receive PSID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PositiveID and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PSID Stock News HeadlinesFinancial Contrast: PositiveID (OTCMKTS:PSID) & MariMed (OTCMKTS:MRMD)September 28, 2025 | americanbankingnews.comPositiveID Stock Price History - Investing.comJuly 31, 2025 | investing.comGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns. | Weiss Ratings (Ad)Five Principles Of Positive Psychology To Boost HappinessApril 12, 2023 | forbes.comColumbia man arrested on suspicion of murder after body found at residence on High Quest Drive - Yahoo NewsOctober 11, 2022 | news.yahoo.comBody of missing kayaker found after water search in Chelmsford - Yahoo! VoicesOctober 4, 2022 | yahoo.comGlobal Blood Glucose Meters Pipeline Market Report 2022: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies - ResearchAndMarkets.com - Business WireSeptember 28, 2022 | businesswire.comBuckroe Beach homes evacuated after crews find possible explosive munition - Yahoo! VoicesSeptember 27, 2022 | yahoo.comSee More Headlines PSID Stock Analysis - Frequently Asked Questions How have PSID shares performed this year? PositiveID's stock was trading at $0.0001 at the beginning of the year. Since then, PSID stock has increased by 0.0% and is now trading at $0.0001. How do I buy shares of PositiveID? Shares of PSID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PositiveID own? Based on aggregate information from My MarketBeat watchlists, some other companies that PositiveID investors own include Vuzix (VUZI), Marijuana Company of America (MCOA), Bridgeline Digital (BLIN), InterCloud Systems (ICLD), XTI Aerospace (XTIA), DICK'S Sporting Goods (DKS) and Precipio (PRPO). Company Calendar Today10/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryMeasuring And Control Equipment Current SymbolOTCMKTS:PSID CIK1347022 Webwww.psidcorp.com Phone561-805-8000Fax561-805-8001Employees9Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:PSID) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredThis soon could be the most precious company in AmericaCurrently, a brand-new, all-American factory outside San Antonio is becoming the most significant site in the ...True Market Insiders | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredChina’s New Gold Play Could Make your Income SoarChina's New Gold Move Could Pay You up to $1,152/month. China just announced plans to store other nations' ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PositiveID Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PositiveID With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.